Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-03-17

Clinical Trial Update: A Comparison of Islet Cell Transplantation With Medical Therapy for the Treatment of Diabetic Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing islet cell transplantation with medical therapy for diabetic retinopathy and diabetic macular edema has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Islet cell transplantation

Snippet

Sponsor: University of British Columbia | Conditions: Diabetic Retinopathy, Diabetic Macular Edema | Phase 3 | Status: WITHDRAWN